Markets Climb for Day Two as Global Cues Trump Caution


Markets Climb for Day Two as Global Cues Trump Caution
  • Sensex and Nifty rose for a second straight session, supported by positive global cues after the US Fed’s rate cut.
  • Metals, realty, and energy stocks led the rally, while midcap and smallcap indices outperformed.
  • Paytm, Wipro, Tata Steel, BEL, Biocon, and NLC India saw action on company-specific developments.
Indian equity markets continued their upward momentum on Friday, December 12, extending gains for the second consecutive session. Benchmark indices Sensex and Nifty 50 closed higher, supported by positive global cues after the US Federal Reserve’s recent interest rate cut, which improved investor confidence across global markets.
The BSE Sensex rose 450 points, or 0.53 percent, to close at 85,267.66, while the Nifty 50 gained 148 points, or 0.57 percent, settling at 26,046.95. Broader markets also mirrored the positive trend, with the BSE Midcap index climbing 1.14 percent and the Smallcap index advancing 0.65 percent, indicating broad-based buying interest.
Market experts said sentiment remained strong throughout the session, driven by steady buying in heavyweight stocks. Ajit Mishra, Senior Vice President – Research at Religare Broking Ltd, noted that the markets opened on a positive note and witnessed some early volatility, but buying support soon returned. He added that the Nifty closed near the day’s high, reflecting strength across most sectors.
All key sectors except FMCG contributed to the rally, with metals, realty, and energy stocks leading the gains. The broader indices also moved in line with the benchmarks, highlighting improved market breadth”, Mishra said.
Global cues played a major role in lifting domestic sentiment. The US Federal Reserve’s rate-cut stance boosted risk appetite among investors, encouraging flows into equity markets worldwide. On the domestic front, steady retail participation and consistent mutual fund inflows supported market stability. However, foreign institutional investor (FII) activity remained mixed due to currency volatility and ongoing discussions related to US–India trade dynamics.
As investors look ahead to the next trading session, several stocks are expected to remain in focus due to company-specific developments.
Paytm announced that it has infused an additional Rs 2,250 crore into its wholly owned subsidiary, Paytm Payments Services Ltd, through a rights issue. The investment, completed on December 12, 2025, is aimed at strengthening the subsidiary’s capital base and supporting its long-term growth plans.
Wipro continued to attract attention after announcing an expansion of its long-standing partnership with Google Cloud. The collaboration will focus on adopting Gemini Enterprise to enhance enterprise productivity and speed up digital transformation for global clients.
KEC International, part of the RPG Group, reported securing fresh orders worth Rs 1,150 crore across its transmission and distribution and civil segments. Notably, the company’s India transmission arm won its largest-ever order from a private-sector client, involving a 765 kV transmission line and a 765/400 kV AIS substation, to be executed on a turnkey basis.
Tata Steel remained in focus as its strategy to expand capacity in India by nearly 50 percent is expected to strengthen its position in the fast-growing domestic steel market. The expansion is also likely to improve raw material security and support the company’s entry into western India.
SAIL, the state-run steel producer, reported a 14 percent year-on-year increase in sales to 12.7 million tonnes during the April–November 2025 period. The performance came despite challenges such as pricing pressure and fluctuating demand.
Bharat Electronics Ltd (BEL) announced that it has received new orders worth Rs 776 crore since its previous update in November. The fresh orders strengthen the company’s order book and support its growth outlook for the current financial year.
Dr Reddy’s Laboratories was also in focus after the US Food and Drug Administration (USFDA) concluded both a Good Manufacturing Practices (GMP) inspection and a Pre-Approval Inspection at the company’s formulations facility in Andhra Pradesh.
Biocon saw interest after its subsidiary, Biocon Biologics, entered into a global settlement and licensing agreement to market its biosimilar Aflibercept worldwide, expanding an earlier agreement that covered only the US and Canada.
Godawari Power and Ispat announced plans to significantly expand its Battery Energy Storage System capacity from 10 GWh to 40 GWh, with a revised investment of Rs 1,625 crore, to be executed in two phases.
Lastly, NLC India said its subsidiary has formed a joint venture with PTC India to develop green energy projects of up to 2,000 MW in phases, starting with around 500 MW.
With strong global cues, healthy domestic flows, and active stock-specific triggers, market participants will closely watch how momentum carries into the coming sessions.